Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/14/24 18:00 | 6/14/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Eldridge George A | MA | O | SEE REMA | 5 | S.dm | -1,718 | 26.43 | 0 | -65 | 5 | D | |||||||||||||||
6/14/24 18:00 | 6/14/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Verwijs Marinus | MA | O | CHIEF TE | 5 | S.d | -610 | 25.25 | 0 | -24 | -100 | 0 | D | ||||||||||||||
6/14/24 18:00 | 6/13/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Gillies Hunter | MA | O | CHIEF ME | 12 | S.dm | -1,461 | 23.15 | 0 | -63 | 6 | D | |||||||||||||||
5/17/24 19:10 | 5/16/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Noyes Timothy P | MA | DO | CEO | 7 | S.d | -1,186 | 22.60 | 0 | -52 | -100 | 0 | D | ||||||||||||||
4/19/24 18:00 | 4/17/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Dake Benjamin T | MA | O | SEE REMA | 10 | S.dm | -2,382 | 21.43 | 0 | -111 | 1 | D | |||||||||||||||
4/11/24 18:00 | 4/9/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Grayzel David S. | MA | D | 1 | S | -334 | 28.15 | 0 | -12 | 1,799 | I | ||||||||||||||||
2/7/24 18:00 | 2/5/24 | AVTE | Health | Drug | Pharmaceutical Preparations | Niven Ralph | MA | O | CHIEF SC | 4 | S.d | -450 | 16.32 | 0 | -28 | 2 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |